Christine Cezar
About Christine Cezar
Christine Cezar is a Senior Principal Engineer at Bristol Myers Squibb, specializing in Cell Therapy Platform Development in the Greater Seattle Area. She has extensive experience in bioengineering and technology strategy, having worked at Juno Therapeutics, the FDA, and several academic institutions.
Current Position at Bristol Myers Squibb
Christine Cezar serves as a Senior Principal Engineer, Cell Therapy Platform Development at Bristol Myers Squibb in the Greater Seattle Area. In this role, she leverages her extensive experience in biomedical engineering and cell therapy to contribute to the development and implementation of advanced cell therapy platforms.
Previous Role at Juno Therapeutics
At Juno Therapeutics, Inc., Christine Cezar held the position of Scientist, Technology Strategy & Innovation from 2018 to 2020 in the Greater Seattle Area. In this role, she focused on advancing technology strategy and fostering innovation in the field of biotechnology.
Biomedical Engineering at FDA
Christine Cezar worked as a Biomedical Engineer at the FDA, Center for Devices and Radiological Health from 2016 to 2018 in the Washington D.C. Metro Area. Her work involved regulatory oversight and evaluation of innovative medical devices to ensure their safety and efficacy.
Educational Background
Christine Cezar holds a Doctor of Philosophy (PhD) and a Master of Science (MS) in Engineering Sciences from Harvard University. She also earned a Bachelor of Science (BS) in Bioengineering from the University of Washington. Her academic background has provided her with a solid foundation in engineering and bioengineering principles.
Research and Fellowships
Christine Cezar has had a prolific career in research and fellowships. She was a Postdoctoral Fellow at the Wyss Institute for Biologically Inspired Engineering, a Mary Gates Research Scholar, and an Engineered Biomaterials Research Scholar at the University of Washington. Additionally, she participated in the VentureLabs Fellowship at Flagship Ventures and was a fellow in the Startup Leadership Program in Greater Boston Area.